Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CK.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CK.1.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
CM.8.1.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
CM.8.1.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
CM.8.1.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CM.8.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
CM.8.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.8.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CM.8.1.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.8.1.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
CA.3.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
CA.3.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
CA.3.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CA.3.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
CA.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CA.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
CA.3.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CA.3.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.61ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.5.2.61ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.5.2.61ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.5.2.61ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.5.2.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.61NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.5.2.61NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.61ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XBB.2.5ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XBB.2.5ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XBB.2.5ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBB.2.5ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XBB.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
XBB.2.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.2.5ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
ED.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
ED.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
ED.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
ED.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
ED.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ED.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
ED.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
ED.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BU.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BU.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BU.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BU.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BU.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BU.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BU.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used